Presented by Immersed: The world’s first work headset is already the #1 productivity app in the Meta Quest ecosystem. Access pre-IPO pricing.
🔥 Good Morning from Top Tickers
One Vaccine Headline Pushes a Stock Up 7% Pre-Market
A virus headline is doing the heavy lifting for one corner of biotech this morning, while index mechanics are reminding everyone that boring catalysts still move stocks. Energy is catching a bid as the AI power thesis continues to draw capital toward the cleanest large-cap operators.
The pain is concentrated in two very different places: a commodity name that couldn't dress up a weak quarter, and a high-flying software story where expectations finally outran the print. Sometimes the best quarter on the tape is the one that gets punished hardest.
🤝 Sponsored By Immersed
1.5 Million Users Onboard This Pre-IPO Company
Immersed stands out for one big reason: people already rely on it to do their jobs.
1.5M+ professionals onboarded to date
Users spend 40–60 hours per week working inside it
#1 productivity app in the Meta Quest ecosystem
Partnerships with Meta, Google, Intel, and Qualcomm
Reserved NASDAQ ticker: $IMRS
Early investors qualify for up to 20% bonus shares
Access Pre-IPO pricing at $0.72 per share, before public markets weigh in.
🚀 Pre-Market Movers
The Biggest Gainers, Ranked
Moderna (MRNA): +6.8%
The biotech is ripping after a U.S. citizen tested positive for hantavirus and a second American showed symptoms but hadn't yet been confirmed. Moderna disclosed early-stage work on a hantavirus vaccine last week, which suddenly looks a lot more relevant to traders this morning.
Lumentum (LITE): +6.3%
The optical components maker is joining the Nasdaq 100 on May 18, replacing CoStar. Index inclusion forces passive funds to buy, and traders are front-running that flow.
Intel (INTC): +4.4%
The post-earnings rally just won't quit. Intel is now up nearly 100% from where it traded before its April 23 report, and the bid keeps building. After years of being the chip story nobody wanted to tell, it's becoming a momentum trade.
Constellation Energy (CEG): +1.7%
The nuclear and clean-energy operator blew past Q1 revenue expectations by a wide margin, and earnings cleared the bar as well. With hyperscalers racing to lock up baseload power for AI data centers, Constellation is the cleanest large-cap way to play that demand.
📉 Pre-Market Movers
The Biggest Losers, Ranked
Mosaic (MOS): -6.7%
Phosphate prices have been the soft spot in the fertilizer trade all year, and Mosaic's Q1 print made the damage official with a sharp earnings miss. When the underlying commodity isn't cooperating, there's nowhere to hide on the income statement, and the tape is treating this as confirmation rather than surprise.
AppLovin (APP): -2.3%
The stock is down 24% YTD, and the selling hasn't stopped. An ongoing SEC probe into whether the company violated partner service agreements to juice ad targeting, plus a string of short-seller reports, has gutted the bull case that drove last year's run.
Palantir (PLTR): -2.1%
Last week, Palantir delivered the kind of quarter most software companies dream about. However, the stock has continued to fall since. When expectations and valuations are stretched, even great isn't great enough.
🤝 Sponsored By Immersed
A Rare Pre-IPO Company Scaling Significant Revenue
Immersed stands out for one big reason: people already rely on it to do their jobs.
1.5M+ professionals onboarded to date
Users spend 40–60 hours per week working inside it
#1 productivity app in the Meta Quest ecosystem
Partnerships with Meta, Google, Intel, and Qualcomm
Reserved NASDAQ ticker: $IMRS
Early investors qualify for up to 20% bonus shares
Access Pre-IPO pricing at $0.72 per share, before public markets weigh in.
👀 What We’re Watching
Here’s One Ticker That’s Trending Today
Rigetti Computing (RGTI)
Rigetti reports Q1 earnings after the close today, and it's the first print since the company launched its 108-qubit Cepheus platform and announced a $100 million UK investment. Retail chatter across Stocktwits and Reddit has been building all week, with traders debating whether the recent Novera system orders and the new platform actually translate into recognized revenue or just another round of forward-looking talk.
The stock has round-tripped most of its 2025 quantum rally, and tonight's print could be the catalyst that either restarts the trade or confirms what bears have been saying about the gap between qubit counts and commercial reality.
How are you feeling today?
This message is a paid advertisement for Immersed. Top Tickers receives a flat fee from Investing Channel totaling up to $2,000. Other than the compensation received for this advertisement sent to subscribers, Top Tickers and its principals are not affiliated with Immersed. This advertisement is sponsored by a third-party Reg A crowdfunding issuer and is for informational purposes only. Top Tickers does not endorse or recommend any specific offering, and this advertisement should not be construed as a recommendation to invest. Investing in securities, including those offered through Reg CF crowdfunding, involves risk, including the potential loss of principal. These investments are speculative, illiquid, and may involve a higher degree of risk compared to more traditional investments. Top Tickers has not verified the information provided by the advertiser, and we encourage readers to conduct their own due diligence and consult with a licensed financial advisor or other qualified professional before making any investment decision. By engaging with this advertisement, you acknowledge that The Street Sheet and its affiliates are not responsible for any decisions or actions taken based on the information provided in this advertisement. All investments carry risks, and past performance is not indicative of future results. Readers should carefully review all information provided by the issuer, including the offering circular and any other available materials, prior to investing. Top Tickers may receive compensation from the advertiser for promoting this offering. Top Tickers and its principals do not own any of the stocks or shares mentioned in this email or in the article that this email links to. Top Tickers is a research service not owned or managed by registered brokers and therefore this site does not make any investment recommendations. The information provided in this newsletter is not guaranteed as to its accuracy or completeness. Each user of Top Tickers chooses to do trades at their sole discretion and risk. Top Tickers is not responsible for gains/losses that may result in the trading of these securities. This newsletter includes paid advertisements. The source of all third-party content in which Top Tickers receives some sort of compensation is clearly and prominently identified herein as "ad", "Sponsored", or “Together With”. Although we have sent you these advertisements, SS does not specifically endorse any third-party product nor is it responsible for the content, the accuracy, or the completeness of the advertisement or the experience with the third-party advertiser. Furthermore, we make no guarantee or warranty about what is in the advertisement. All investments involve risk, losses may exceed the principal invested, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. This communication from Top Tickers is for informational purposes only. It is not intended to serve as a recommendation to buy, sell, or hold any security and is not an offer or sale of a security. Information contained within should not be perceived as a research report and is not intended to serve as the basis for any investment decision. Any third-party views reflected herein do not reflect the opinion of Top Tickers. All investments involve risk and the past performance of a security does not guarantee future results or returns. There is always the potential for financial loss when investing in securities or other financial products. The information contained in this newsletter is subject to change without notice, and we do not undertake any obligation to update it. Readers are encouraged to conduct their own research and due diligence and seek advice from licensed professionals regarding their specific financial needs and circumstances. By reading this newsletter, you agree to hold us harmless from any and all losses, liabilities, costs, or expenses arising from your use or reliance on the information provided. There is no warranty as to the accuracy or completeness of the factual matters included in any advertisement or sponsored content in the newsletter. You have not performed any research on any entity, or its business, that advertises or submits any sponsored content. Top Tickers is reader-supported. When you buy through links on our site, we may earn a commission.